ConductScience.org, home

Paper40834985

Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis.

Ghosh C and 12 others. Cancer Lett, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis. Papers, record 40834985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40834985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis.
PubMed
Journal
Cancer Lett
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.46, provisional
iCite
Revised in PubMed
2026-09-19
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghosh CChandrayee
2Khaket TPTejinder Pal
3Gunda VViswanath
4Yang ZZhongyue
5Hu JJiangnan
6Alamaw EDEden Demissie
7Zhang LLisa
8Zhang YQYa-Qin
9Shen MMin
10Tabdili YYasmine
11Boufraqech MMyriem
12Kassu RRodas
13Kebebew EElectron

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
ThiazolesMajor topic
AuranofinMajor topic
Oxidative StressMajor topic
Thyroid Carcinoma, AnaplasticMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Thyroid NeoplasmsMajor topic
Humans
Nitro Compounds
Drug Synergism
Animals
Cell Line, Tumor
Cell Proliferation
Xenograft Model Antitumor Assays
Reactive Oxygen Species
Mice, Nude
Mice
Cell Movement
Female

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIA BC011286Intramural NIH HHSUnited StatesZIABC011286PubMed

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in41314952
Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990].
https://conductscience.org/library/papers/41314952

Source PubMed

Download CSV of comments and corrections

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139329036Estimation of Serum Malondialdehyde (a Marker of Oxidative Stress) as a Predictive Biomarker for the Severity of Coronary Artery Disease (CAD) and Cardiovascular Outcomes.Cureus2024https://conductscience.org/library/papers/39329036PubMed
223254900The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease.Kidney Int2013https://conductscience.org/library/papers/23254900PubMed
338636790Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer.Chem Biol Interact2024https://conductscience.org/library/papers/38636790PubMed
436852389Drug Repurposing: An Effective Tool in Modern Drug Discovery.Russ J Bioorg Chem2023https://conductscience.org/library/papers/36852389PubMed
527821451Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/27821451PubMed
632284020Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.Thyroid2020https://conductscience.org/library/papers/32284020PubMed
729072975Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.J Clin Oncol2018https://conductscience.org/library/papers/29072975PubMed
829501728Targeting of cathepsin C induces autophagic dysregulation that directs ER stress mediated cellular cytotoxicity in colorectal cancer cells.Cell Signal2018https://conductscience.org/library/papers/29501728PubMed
934638857ROS/TNF-α Crosstalk Triggers the Expression of IL-8 and MCP-1 in Human Monocytic THP-1 Cells via the NF-κB and ERK1/2 Mediated Signaling.Int J Mol Sci2021https://conductscience.org/library/papers/34638857PubMed
1031937621A Combinatorial Strategy for Targeting BRAF V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).Clin Cancer Res2020https://conductscience.org/library/papers/31937621PubMed
1136775962Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma.Cancer Med2023https://conductscience.org/library/papers/36775962PubMed
1235624835Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer.Antioxidants (Basel)2022https://conductscience.org/library/papers/35624835PubMed
1337778414Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells.Life Sci2023https://conductscience.org/library/papers/37778414PubMed
1439084502Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.Chem Biol Interact2024https://conductscience.org/library/papers/39084502PubMed
1536014444Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels.Molecules2022https://conductscience.org/library/papers/36014444PubMed
1637121274High-throughput approaches to uncover synergistic drug combinations in leukemia.SLAS Discov2023https://conductscience.org/library/papers/37121274PubMed
1714640029Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis.Amyloid2003https://conductscience.org/library/papers/14640029PubMed
1835201489The gold complex auranofin: new perspectives for cancer therapy.Discov Oncol2021https://conductscience.org/library/papers/35201489PubMed
1925560241Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.Redox Biol2015https://conductscience.org/library/papers/25560241PubMed
2033812801Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.Redox Biol2021https://conductscience.org/library/papers/33812801PubMed

See all 54 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42035477CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.Mol Carcinog2026https://conductscience.org/library/papers/42035477PubMed
41963956Mitophagy in bladder cancer: a double-edged sword in tumor progression and therapy.J Transl Med2026https://conductscience.org/library/papers/41963956PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HMOX13162PubTator's text mininghttps://conductscience.org/library/genes/3162

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40834985

GET https://conductscience.org/api/papers/v1/40834985/references?page=2